Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis

US Patent 11884728 · Granted Jan 30, 2024

Estimated economic value: $33,927,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory t cell levels or activity for treatment of disease 2022
Reducing systemic regulatory t cell levels or activity for treatment of disease 2022
Reducing systemic regulatory t cell levels or activity for treatment of disease 2022
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2021